Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.65M $1.02B June 30, 2015
ClearBridge Advisors 9.59M $610.35M March 31, 2015
Vanguard 8.58M $493.71M June 30, 2015
BB Biotech AG 5.93M $341.24M June 30, 2015
Waddell & Reed Financial 5.45M $347.03M March 31, 2015
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
Artisan Partners Limited Partnership 3.85M $237.86M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 3.02M $173.54M June 30, 2015
T. Rowe Price Associates 2.68M $165.36M Dec. 31, 2014
BlackRock Fund Advisors 2.62M $150.66M June 30, 2015
SUSQUEHANNA INTERNATIONAL 2.60M $100.91M Sept. 30, 2014
STATE STREET CORPORATION 2.50M $143.92M June 30, 2015
EQUITEC SPECIALISTS 2.39M $2.39M Dec. 31, 2014
Jennison Associates 2.20M $95.09M March 31, 2014
BVF 2.16M $25.94M June 30, 2012
Gail Mannix 2.12M $56.95M June 30, 2013
Franklin Resources 2.11M $91.17M March 31, 2014
LORD, ABBETT & CO 2.11M $56.65M June 30, 2013
Tocqueville Asset Management 2.10M $35.50M March 31, 2013